— Publications

2017 Annual Business Report


Download
All financial reports


— Media releases


July 2, 2018

Valneva Announces Significant Progress of its Lyme Disease Vaccine Candidate

Read more


— Financial calendar


Upcoming events
HY 2018 Financial Statements
August 2, 2018

All dates




— Meet us

Goldman Sachs 8th Annual Biotech Symposium
September 7, London

European Large & Midcap Event
October 8-9, Paris

World Vaccine Congress Europe
October 29-31, Lisbon

Stifel 2018 Healthcare Conference
Lyme Disease

Download brochure









    

— Our responsibility

Committed to people, protecting lives and the environment


Learn more

play video Valneva's CEO Thomas Lingelbach
comments on Group Strategy

Subscribe to our Newsletter

mail-icon-lightblue.png


Contact Investor Relations

speech-balloon-icon-white.png

Please update your browser...